BIOMAT Database Logo BIOMAT Database Logo

[Alteration of platelet population in thrombotic diseases]. 1984

K Tanoue

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D001810 Blood Volume Volume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME. Blood Volumes,Volume, Blood,Volumes, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D013928 Thromboxane A2 An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Rabbit Aorta Contracting Substance,A2, Thromboxane

Related Publications

K Tanoue
Platelet 5-hydroxy-tryptamine in thrombotic and non-thrombotic diseases.
May 1975, Age and ageing,
K Tanoue
Platelet purinergic receptors and non-thrombotic diseases.
February 2024, British journal of pharmacology,
K Tanoue
[Alteration in the expression of platelet microRNAs in diseases with abnormal platelet activation].
November 2018, Orvosi hetilap,
K Tanoue
[Clinical significance of determining circulatory platelet aggregates in thrombotic diseases].
July 1984, Zhonghua yi xue za zhi,
K Tanoue
[Clinical significance of protein Z alteration in patients with cardio-cerebral thrombotic diseases].
November 2004, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
K Tanoue
New advances in treating thrombotic diseases: GPVI as a platelet drug target.
September 2014, Drug discovery today,
K Tanoue
[Factors influencing platelet function in elderly patients with chronic phase thrombotic diseases].
August 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
K Tanoue
Platelet polymorphisms in thrombotic disorders.
June 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
K Tanoue
Platelet activation in thrombotic disorders.
February 1993, Nouvelle revue francaise d'hematologie,
K Tanoue
Alteration of platelet adhesion to glass in vascular disorders and certain other diseases.
May 1972, American journal of clinical pathology,
Copied contents to your clipboard!